{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T19:08:16Z","timestamp":1790708896585,"version":"4.1.0"},"reference-count":27,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>CD137 (4-1BB, TNFRSF9) plays a crucial role in T-cell activation, proliferation, and antiviral immunity. Biallelic TNFRSF9 variants cause CD137 deficiency, a rare inborn error of immunity characterized by Epstein-Barr virus (EBV)-induced hemophagocytic lymphohistiocytosis (HLH) and lymphoproliferation\/malignancy. In this study, we aimed to characterize the clinical, immunological, and genetic spectrum of CD137 deficiency to provide insights into patient management. We recruited two patients carrying the same homozygous large deletion encompassing exons 1-6 of the TNFRSF9 gene and reviewed previously reported cases. The genetic defect was identified by whole-exome sequencing and confirmed by multiplex ligation-dependent probe amplification. Reported variants included missense, splice-site, and frameshift variants, large deletions, and compound heterozygous variants. A total of 14 patients, including the two newly reported cases, exhibited recurrent sinopulmonary infections and EBV viremia. HLH occurred in four patients (28.5%), including both newly reported patients, while lymphoma developed in seven patients (50%). Most patients were of Middle Eastern origin, and parental consanguinity was documented in 12 of 14 patients (85%). Hematopoietic stem cell transplantation (HSCT) was performed in 35.7% (5\/14) of patients, with a median age of 9 years (range, 7-17 years) among four reported cases. All transplanted patients were alive at the last follow-up, whereas mortality occurred exclusively among non-transplanted patients, including EBV-positive cases. These findings expand the phenotypic and mutational spectrum of CD137 deficiency and highlight the importance of incorporating copy number variant analysis into exome-based diagnostic pipelines when conventional single-nucleotide variant analysis is inconclusive. HSCT remains the only potentially curative treatment, and early molecular diagnosis is essential to enable timely consideration of HSCT and to mitigate life-threatening EBV-driven immunopathology.<\/jats:p>","DOI":"10.1093\/cei\/uxag021","type":"journal-article","created":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T11:43:07Z","timestamp":1778154187000},"source":"Crossref","is-referenced-by-count":0,"title":["CD137 deficiency patients: two new patients and review of the literature"],"prefix":"10.1093","volume":"220","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-6186-1138","authenticated-orcid":false,"given":"Zehra","family":"Genc Ozbay","sequence":"first","affiliation":[{"name":"Division of Pediatric Immunology, Department of Pediatrics, Hacettepe University Medical School , Ankara ,","place":["Turkey"]},{"name":"\u0130hsan Do\u011framac\u0131 Children\u2019s Hospital, Hacettepe University , Ankara ,","place":["Turkey"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Busra","family":"Kocali","sequence":"additional","affiliation":[{"name":"Division of Pediatric Immunology, Department of Pediatrics, Hacettepe University Medical School , Ankara ,","place":["Turkey"]},{"name":"\u0130hsan Do\u011framac\u0131 Children\u2019s Hospital, Hacettepe University , Ankara ,","place":["Turkey"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deniz","family":"Ilgun Gurel","sequence":"additional","affiliation":[{"name":"Division of Pediatric Immunology, Department of Pediatrics, Hacettepe University Medical School , Ankara ,","place":["Turkey"]},{"name":"\u0130hsan Do\u011framac\u0131 Children\u2019s Hospital, Hacettepe University , Ankara ,","place":["Turkey"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ismail","family":"Yaz","sequence":"additional","affiliation":[{"name":"Department of Immunology, Pediatric Basic Sciences, Institute of Child Health, Hacettepe University , Ankara ,","place":["Turkey"]},{"name":"Pediatric Immunology Laboratory, Department of Pediatrics, Hacettepe University Medical School , Ankara ,","place":["Turkey"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baris","family":"Ulum","sequence":"additional","affiliation":[{"name":"Department of Immunology, Pediatric Basic Sciences, Institute of Child Health, Hacettepe University , Ankara ,","place":["Turkey"]},{"name":"Pediatric Immunology Laboratory, Department of Pediatrics, Hacettepe University Medical School , Ankara ,","place":["Turkey"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilek","family":"Aktas","sequence":"additional","affiliation":[{"name":"Damagen Genetic Diagnostic Center , Ankara ,","place":["Turkey"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ece","family":"Ozogul","sequence":"additional","affiliation":[{"name":"Department of Pathology, Hacettepe University Medical School , Ankara ,","place":["Turkey"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elif","family":"Soyak Aytekin","sequence":"additional","affiliation":[{"name":"Division of Pediatric Immunology, Department of Pediatrics, Hacettepe University Medical School , Ankara ,","place":["Turkey"]},{"name":"\u0130hsan Do\u011framac\u0131 Children\u2019s Hospital, Hacettepe University , Ankara ,","place":["Turkey"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saliha","family":"Esenboga","sequence":"additional","affiliation":[{"name":"Division of Pediatric Immunology, Department of Pediatrics, Hacettepe University Medical School , Ankara ,","place":["Turkey"]},{"name":"\u0130hsan Do\u011framac\u0131 Children\u2019s Hospital, Hacettepe University , Ankara ,","place":["Turkey"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aysegul","family":"Uner","sequence":"additional","affiliation":[{"name":"Department of Pathology, Hacettepe University Medical School , Ankara ,","place":["Turkey"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baris","family":"Kuskonmaz","sequence":"additional","affiliation":[{"name":"\u0130hsan Do\u011framac\u0131 Children\u2019s Hospital, Hacettepe University , Ankara ,","place":["Turkey"]},{"name":"Division of Pediatric Hematology, Department of Pediatrics, Hacettepe University Medical School , Ankara ,","place":["Turkey"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2213-4627","authenticated-orcid":false,"given":"Deniz","family":"Cagdas","sequence":"additional","affiliation":[{"name":"Division of Pediatric Immunology, Department of Pediatrics, Hacettepe University Medical School , Ankara ,","place":["Turkey"]},{"name":"\u0130hsan Do\u011framac\u0131 Children\u2019s Hospital, Hacettepe University , Ankara ,","place":["Turkey"]},{"name":"Department of Immunology, Pediatric Basic Sciences, Institute of Child Health, Hacettepe University , Ankara ,","place":["Turkey"]},{"name":"Pediatric Immunology Laboratory, Department of Pediatrics, Hacettepe University Medical School , Ankara ,","place":["Turkey"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,5,18]]},"reference":[{"key":"2026092914372972800_uxag021-B1","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.jaci.2019.03.002","article-title":"Immunodeficiency and EBV-induced lymphoproliferation caused by 4-1BB deficiency","volume":"144","author":"Alosaimi","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"2026092914372972800_uxag021-B2","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1182\/blood.2019000644","article-title":"CD137 deficiency causes immune dysregulation with predisposition to lymphomagenesis","volume":"134","author":"Somekh","year":"2019","journal-title":"Blood"},{"key":"2026092914372972800_uxag021-B3","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1084\/jem.20161846","article-title":"Human immunity against EBV-lessons from the clinic","volume":"214","author":"Tangye","year":"2017","journal-title":"J Exp Med"},{"key":"2026092914372972800_uxag021-B4","doi-asserted-by":"crossref","first-page":"13765","DOI":"10.1073\/pnas.95.23.13765","article-title":"Inactivating mutations in an SH2 domain-encoding gene in X-linked lymphoproliferative syndrome","volume":"95","author":"Nichols","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026092914372972800_uxag021-B5","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/nyas.12937","article-title":"Primary immunodeficiencies and the control of epstein-barr virus infection","volume":"1356","author":"Palendira","year":"2015","journal-title":"Ann N Y Acad Sci"},{"key":"2026092914372972800_uxag021-B6","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1182\/blood-2010-06-284935","article-title":"X-linked lymphoproliferative disease due to SAP\/SH2D1A deficiency: a multicenter study on the manifestations, management and outcome of the disease","volume":"117","author":"Booth","year":"2011","journal-title":"Blood"},{"key":"2026092914372972800_uxag021-B7","doi-asserted-by":"crossref","first-page":"9958","DOI":"10.1074\/jbc.RA118.003176","article-title":"Crystal structures of the human 4-1BB receptor bound to its ligand 4-1BBL reveal covalent receptor dimerization as a potential signaling amplifier","volume":"293","author":"Bitra","year":"2018","journal-title":"J Biol Chem"},{"key":"2026092914372972800_uxag021-B8","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s12026-025-09627-4","article-title":"A patient with RFX5 variant causing an expression defect in both HLA ABC and HLA DR","volume":"73","author":"Goktas","year":"2025","journal-title":"Immunol Res"},{"key":"2026092914372972800_uxag021-B9","doi-asserted-by":"crossref","first-page":"e20250002","DOI":"10.70962\/jhi.20250002","article-title":"The 2024 update of IUIS phenotypic classification of human inborn errors of immunity","volume":"1","author":"Bousfiha","year":"2025","journal-title":"J Hum Immun"},{"key":"2026092914372972800_uxag021-B10","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the world health organization classification of haematolymphoid tumours: lymphoid neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"key":"2026092914372972800_uxag021-B11","doi-asserted-by":"crossref","first-page":"108639","DOI":"10.1016\/j.clim.2020.108639","article-title":"Successful hematopoietic stem cell transplantation in a 4-1BB deficient patient with EBV-induced lymphoproliferation","volume":"222","author":"Wildermann","year":"2021","journal-title":"Clin Immunol"},{"key":"2026092914372972800_uxag021-B12","doi-asserted-by":"crossref","first-page":"e20211682","DOI":"10.1084\/jem.20211682","article-title":"Inherited TNFSF9 deficiency causes broad epstein-barr virus infection with EBV+ smooth muscle tumors","volume":"219","author":"Fournier","year":"2022","journal-title":"J Exp Med"},{"key":"2026092914372972800_uxag021-B13","doi-asserted-by":"crossref","first-page":"e1448","DOI":"10.1002\/cti2.1448","article-title":"CD137 deficiency because of two novel biallelic TNFRSF9 mutations in a patient presenting with severe EBV-associated lymphoproliferative disease","volume":"12","author":"Shen","year":"2023","journal-title":"Clin Transl Immunology"},{"key":"2026092914372972800_uxag021-B14","doi-asserted-by":"crossref","first-page":"1605221","DOI":"10.3389\/fimmu.2025.1605221","article-title":"Clinical and functional characterization of a novel TNFRSF9 variant causing immune dysregulation with predisposition to EBV-driven lymphomagenesis","volume":"16","author":"Zhao","year":"2025","journal-title":"Front Immunol"},{"key":"2026092914372972800_uxag021-B15","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1084\/jem.20190678","article-title":"Concomitant PIK3CD and TNFRSF9 deficiencies cause chronic active epstein-barr virus infection of T cells","volume":"216","author":"Rodriguez","year":"2019","journal-title":"J Exp Med"},{"key":"2026092914372972800_uxag021-B16","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1093\/intimm\/dxf080","article-title":"4-1BB co-stimulation enhances human CD8(+) T cell priming by augmenting the proliferation and survival of effector CD8(+) T cells","volume":"14","author":"Laderach","year":"2002","journal-title":"Int Immunol"},{"key":"2026092914372972800_uxag021-B17","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.cmi.2022.10.003","article-title":"When to suspect inborn errors of immunity in epstein\u2013barr virus\u2013related lymphoproliferative disorders","volume":"29","author":"Sacco","year":"2023","journal-title":"Clin Microbiol Infect"},{"key":"2026092914372972800_uxag021-B18","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"COVID-19: consider cytokine storm syndromes and immunosuppression","volume":"395","author":"Mehta","year":"2020","journal-title":"Lancet"},{"key":"2026092914372972800_uxag021-B19","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMra2026131","article-title":"Cytokine storm","volume":"383","author":"Fajgenbaum","year":"2020","journal-title":"N Engl J Med"},{"key":"2026092914372972800_uxag021-B20","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1056\/NEJMcps2111163","article-title":"Calm before the storm","volume":"386","author":"Braga Neto","year":"2022","journal-title":"N Engl J Med"},{"key":"2026092914372972800_uxag021-B21","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.1002\/cncr.30826","article-title":"A consensus review on malignancy-associated hemophagocytic lymphohistiocytosis in adults","volume":"123","author":"Daver","year":"2017","journal-title":"Cancer"},{"key":"2026092914372972800_uxag021-B22","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/S1473-3099(07)70290-6","article-title":"Infections associated with haemophagocytic syndrome","volume":"7","author":"Rouphael","year":"2007","journal-title":"Lancet Infect Dis"},{"key":"2026092914372972800_uxag021-B23","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1146\/annurev-immunol-032414-112326","article-title":"The immunology of epstein-barr virus-induced disease","volume":"33","author":"Taylor","year":"2015","journal-title":"Annu Rev Immunol"},{"key":"2026092914372972800_uxag021-B24","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1182\/blood-2017-06-788349","article-title":"Confirmed efficacy of etoposide and dexamethasone in HLH treatment: long-term results of the cooperative HLH-2004 study","volume":"130","author":"Bergsten","year":"2017","journal-title":"Blood"},{"key":"2026092914372972800_uxag021-B25","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s13045-024-01621-x","article-title":"Hemophagocytic lymphohistiocytosis: current treatment advances, emerging targeted therapy and underlying mechanisms","volume":"17","author":"Wu","year":"2024","journal-title":"J Hematol Oncol"},{"key":"2026092914372972800_uxag021-B26","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/bjh.12386","article-title":"Treatment of epstein barr virus-induced haemophagocytic lymphohistiocytosis with rituximab-containing chemo-immunotherapeutic regimens","volume":"162","author":"Chellapandian","year":"2013","journal-title":"Br J Haematol"},{"key":"2026092914372972800_uxag021-B27","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s00277-010-1114-y","article-title":"Pilot study of pegylated interferon alpha-2a treatment during chemo- and radiotherapy and post-remission maintenance in patients with EBV-positive extranodal NK\/T cell lymphoma","volume":"90","author":"Kim","year":"2011","journal-title":"Ann Hematol"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/220\/1\/uxag021\/68317371\/uxag021.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/220\/1\/uxag021\/68317371\/uxag021.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T18:37:45Z","timestamp":1790707065000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/doi\/10.1093\/cei\/uxag021\/8684113"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,6]]}},"URL":"https:\/\/doi.org\/10.1093\/cei\/uxag021","relation":{},"ISSN":["0009-9104","1365-2249"],"issn-type":[{"value":"0009-9104","type":"print"},{"value":"1365-2249","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026]]},"published":{"date-parts":[[2026]]},"article-number":"uxag021"}}